Dennis Roggenkamp
2PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Oct 22, 2021
Thiamidol® in moderate-to-severe melasma: 24-week, randomized, double-blind, vehicle-controlled clinical study with subsequent regression phase.Dennis Roggenkamp, Adel Sammain, Manuela Fürstenau
|Feb 09, 2021
Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol).Dennis Roggenkamp, Ncoza Dlova, Tobias Mann
Pageof 1
